GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Price-to-Owner-Earnings

Sphere Medical Holding (LSE:SPHR) Price-to-Owner-Earnings : (As of Jun. 02, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Price-to-Owner-Earnings?

As of today (2024-06-02), Sphere Medical Holding's share price is £0.00. Sphere Medical Holding does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Sphere Medical Holding's Price-to-Owner-Earnings or its related term are showing as below:


LSE:SPHR's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 32.19
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-02), Sphere Medical Holding's share price is £0.00. Sphere Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.03. Therefore, Sphere Medical Holding's PE Ratio for today is At Loss.

As of today (2024-06-02), Sphere Medical Holding's share price is £0.00. Sphere Medical Holding's EPS without NRI for the trailing twelve months (TTM) ended in was £-0.03. Therefore, Sphere Medical Holding's PE Ratio without NRI for today is At Loss.


Sphere Medical Holding Price-to-Owner-Earnings Historical Data

The historical data trend for Sphere Medical Holding's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Price-to-Owner-Earnings Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sphere Medical Holding's Price-to-Owner-Earnings

For the Medical Devices subindustry, Sphere Medical Holding's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Price-to-Owner-Earnings falls into.



Sphere Medical Holding Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Sphere Medical Holding's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.00/-0.04
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Sphere Medical Holding Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.